These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 5888085

  • 1. [Treatment of ascites in cirrhosis of the liver].
    Del Solar V, Lobo G, Varela N, Lehmann C.
    Rev Med Chil; 1965 Sep; 93(9):549-56. PubMed ID: 5888085
    [No Abstract] [Full Text] [Related]

  • 2. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L, Candiori R.
    Med Interna (Bucur); 1970 May; 22(5):573-92. PubMed ID: 5426383
    [No Abstract] [Full Text] [Related]

  • 3. [Triamterene in diuretic therapy of cirrhogenic ascites. Modifications of water-saline metabolism induced by its administration alone and in combination with fluprednisolone, methopyrone, mercaptomerine and benzothiazides].
    Ventura E, Loiodice L, Marani L.
    Minerva Med; 1963 Oct 10; 54(81 Suppl):3024-7. PubMed ID: 5877334
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of amiloride (MK 870) on water and electrolyte metabolism in ascitic cirrhotics].
    Vesin P, Roberti A, Viguie R.
    Schweiz Med Wochenschr; 1969 Jan 04; 99(1):21-6. PubMed ID: 5790153
    [No Abstract] [Full Text] [Related]

  • 5. [Renal insufficiency caused by diuretics in liver cirrhosis with ascites].
    Bosch J, Arroyo V, Rodes J, Teres J, Bordas JM, Bruguera M.
    Rev Clin Esp; 1973 Dec 15; 131(5):375-82. PubMed ID: 4779095
    [No Abstract] [Full Text] [Related]

  • 6. Bumetanide in the treatment of hepatic ascites.
    Ring-Larsen H.
    Postgrad Med J; 1975 Dec 15; 51 Suppl 6():77-81. PubMed ID: 1105536
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B, De Colibus V, Napolitano L, Aliperta A, Caldarelli G, Abignente F.
    Clin Ter; 1977 Dec 31; 83(6):625-9. PubMed ID: 343976
    [No Abstract] [Full Text] [Related]

  • 8. [Electrolyte metabolism anomalies in liver cirrhosis].
    Okumura M, Katsuki S.
    Saishin Igaku; 1968 Dec 10; 23(12):2527-33. PubMed ID: 4889816
    [No Abstract] [Full Text] [Related]

  • 9. [On the clinical and metabolic effects of mefruside].
    Costa C, Cordova C.
    Clin Ter; 1971 Sep 10; 58(5):397-408. PubMed ID: 5135606
    [No Abstract] [Full Text] [Related]

  • 10. [Triamterene in the depletive treatment of cirrhosis].
    Ravenni G, Rubegni M, Forconi S.
    Boll Soc Ital Biol Sper; 1964 Apr 15; 40(7):290-3. PubMed ID: 5875781
    [No Abstract] [Full Text] [Related]

  • 11. [Water and salt metabolism in the hepatopathic patient, with special reference to hypokalemia].
    Santagostino A.
    G Gerontol; 1972 Jun 15; 20(6):535-41. PubMed ID: 5046893
    [No Abstract] [Full Text] [Related]

  • 12. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F, Queirolo C, Brignole M, Zangani F.
    Clin Ter; 1980 Jan 31; 92(2):143-53. PubMed ID: 7389274
    [No Abstract] [Full Text] [Related]

  • 13. [Medical treatment of liver cirrhosis].
    Ritland S.
    Tidsskr Nor Laegeforen; 1976 Mar 20; 96(8):509-12. PubMed ID: 1258015
    [No Abstract] [Full Text] [Related]

  • 14. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS, Park GT, Kim YH, Shim SG, Kim JB, Lee OY, Choi HS, Hahm JS, Lee MH.
    Taehan Kan Hakhoe Chi; 2003 Dec 20; 9(4):324-31. PubMed ID: 14695699
    [Abstract] [Full Text] [Related]

  • 15. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis].
    Furukawa T.
    Saishin Igaku; 1965 Jul 20; 20(7):1743-58. PubMed ID: 5884753
    [No Abstract] [Full Text] [Related]

  • 16. [The Kottakis operation combined with drug therapy in the treatment of refractory ascites in liver cirrhosis. Personal observations].
    Viola S, Sindoni G, Burrafato F, Ricotta M, Galanti P, Picone D, Di Francesco OM.
    Minerva Chir; 1981 Sep 15; 36(17):1069-74. PubMed ID: 7290421
    [No Abstract] [Full Text] [Related]

  • 17. [Water-electrolyte disorders in hepatic cirrhosis with ascites].
    Arroyo V, Rodes J, Sánchez-Tapias JM, Bordas JM, Teres J, Brugera M, Gassull MA.
    Rev Clin Esp; 1972 Mar 15; 124(5):469-76. PubMed ID: 5034135
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of the edemato-ascitic syndrome in cirrhotics, role of amiloride (MK870)].
    Quinton A, Bancons J, Dubarry JJ.
    Bord Med; 1972 Oct 15; 5(16):2141-9. PubMed ID: 4640793
    [No Abstract] [Full Text] [Related]

  • 19. [On a particular scheme of multiple drug treatment of ascites in liver cirrhosis].
    Colucci CF, De Luca FP.
    Riforma Med; 1965 Oct 23; 79(43):1188-94. PubMed ID: 5865809
    [No Abstract] [Full Text] [Related]

  • 20. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H, Perret M, Etaix JP.
    J Med Lyon; 1967 Feb 05; 48(114):173-83. PubMed ID: 5600100
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.